PRICE T ROWE ASSOCIATES INC /MD/ - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,400
-20.9%
1,267,232
-0.2%
0.01%
-14.3%
Q2 2023$51,044
+3.7%
1,270,361
+10.2%
0.01%0.0%
Q1 2023$49,213
+65.0%
1,152,516
+85.5%
0.01%
+40.0%
Q4 2022$29,829
-91.9%
621,189
+6284.3%
0.01%
Q3 2022$367,000
+49.8%
9,730
+116.0%
0.00%
Q1 2022$245,000
-36.2%
4,505
-31.4%
0.00%
Q4 2021$384,0006,5670.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders